OTUB2 promotes the progression of endometrial cancer by regulating the PKM2‐mediated PI3K/AKT signaling pathway
Cell Biology International · 2023-02 · 47 (2) · 428-438
DOI: 10.1002/cbin.11950 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Biology International, online erschienen am 31.10.2022. Verfasst von Qian Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of The First of Internal Medicine, Shaanxi Provincial Cancer Hospital, Xi'an, Shannxi, People's Republic of China. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-akt, Endometrial Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Abstract (Originalsprache)
Endometrial carcinoma (EC) morbidity and mortality have been increasing in recent years. Otubain 2 (OTUB2) was shown to be upregulated in EC patients, so the aim of this study was to explore the role of OTUB2 in EC. Cell Counting Kit‐8 (CCK‐8), colony formation, enzyme‐linked immunosorbent assay, the wound healing assay, and Transwell invasion assays were used to investigate the specific role of OTUB2 in EC tumorigenesis. Real‐time polymerase chain reaction and western blot analysis were used to detect the expression of OTUB2 in EC tissues and cells. OTUB2 is upregulated in EC patients and cell lines and is associated with a poor prognosis. The overexpression of OTUB2 promoted glycolysis and induced the proliferation, migration, and invasion of endometrial cancer cells. The silencing of OTUB2 had the opposite effect. In addition, the silencing of OTUB2 significantly suppressed the expression levels of PKM2. Importantly, inhibition of the PKM2/PI3K/AKT signaling pathway significantly reversed the promoting effect of OTUB2 overexpression on EC. OTUB2 regulated the proliferation and invasion of EC cells by regulating the PKM2/PI3K/AKT signaling pathway. OTUB2 may serve as a potential prognostic and therapeutic target in EC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of The First of Internal Medicine, Shaanxi Provincial Cancer Hospital, Xi'an, Shannxi, People's Republic of China.
- Department of The Fourth of Gynecologic Oncology, Shaanxi Provincial Cancer Hospital, Xi'an, Shannxi, People's Republic of China.
- Department of The Second of Gynecologic Oncology, Shaanxi Provincial Cancer Hospital, Xi'an, Shannxi, People's Republic of China.
Zitieren
APA
Zhang, Q., Zhang, J., Yao, A., Tian, X., Han, Z., Yuan, Y., Tao, K., & Yang, X. (2023). OTUB2 promotes the progression of endometrial cancer by regulating the PKM2‐mediated PI3K/AKT signaling pathway. Cell Biology International, 47(2), 428-438. https://doi.org/10.1002/cbin.11950
Vancouver
Zhang Q, Zhang J, Yao A, Tian X, Han Z, Yuan Y, et al. OTUB2 promotes the progression of endometrial cancer by regulating the PKM2‐mediated PI3K/AKT signaling pathway. Cell Biology International. 2023;47(2):428-438. doi:10.1002/cbin.11950
BibTeX
@article{Zhang2023,
author = {Zhang, Qian and Zhang, Jing and Yao, Anmei and Tian, Xiaofei and Han, Zhihong and Yuan, Yuan and Tao, Kai and Yang, Xuemei},
title = {OTUB2 promotes the progression of endometrial cancer by regulating the PKM2‐mediated PI3K/AKT signaling pathway},
journal = {Cell Biology International},
year = {2023},
volume = {47},
number = {2},
pages = {428--438},
doi = {10.1002/cbin.11950}
}
EUVIMED